The Travel Challenge: Clinical Trial Participants Say It's One Of Their Biggest Burdens

By Kyle Renick; Global Study Manager, Suvoda

Among participants who found their trial disruptive, travel to the study clinic outranked time requirements, at-home tasks, and missed work as the main factor. Drawing on CISCRP's Perceptions and Insights Study, which surveyed more than 12,800 people globally, this analysis traces how travel burden shows up before enrollment, during protocol compliance, and in the decision to stay through completion. It considers where distance ranks against factors like reimbursement and study drug details, and which supportive services participants rated most helpful. It also outlines design and communication choices to weigh during protocol development. Explore the data to see how travel logistics may shape who your studies reach and keep.